![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Baxter Provides Updated Financial Outlook for 2016
Positive Sales Mix and Disciplined Expense Management Contribute to Strong First Quarter Performance; Adjusted Earnings...
Johnson & Johnson Reports 2016 First-Quarter Results
Johnson & Johnson announced sales of $17.5 billion for the first quarter of 2016, an...
Boehringer Ingelheim has a successful 2015 financial year with net sales increased by 4.1%
Net sales rise to 14.8 billion euros (currency-adjusted: +4.1 per cent; +11.1 per cent...
Teva to Report First Quarter 2016 Financial Results on May 9, 2016
Teva Pharmaceutical Industries Ltd. announced that it will release its first quarter 2016 financial results...
Teva to Report First Quarter 2016 Financial Results on May 9, 2016
Teva Pharmaceutical Industries Ltd announced that it will release its first quarter 2016 financial results...
Lilly To Provide Detailed Update Of Pipeline And R&D Strategy At Upcoming Investment Community...
Eli Lilly and Company announced it will host a meeting for the investment community, including...
INNATE PHARMA IN-LICENSES OREGA BIOTECH’S FIRST-IN-CLASS ANTI-CD39 CHECKPOINT INHIBITOR PROGRAM
This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the...
CTI BioPharma Announces $15.7 Million Registered Direct Offering
CTI BioPharma Corp. announced that it has entered into an agreement with institutional investors to...
Seattle Genetics, BMS to evaluate Adcetris and Opdivo combination
Seattle Genetics and Bristol-Myers Squibb (BMS) have entered into a clinical trial collaboration agreement to...
Ireland’s Shire to acquire NPS Pharmaceuticals for $5.2bn
Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn....